Clinical Trials Directory

Trials / Sponsors / Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc.

Industry · 6 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingBlinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pn
Pneumonia, Bacterial
Phase 22023-07-22
CompletedStudy to Assess the Efficacy and Safety of Ryanodex as Adjuvant Treatment in Subjects With EHS
Exertional Heat Stroke
Phase 32018-08-19
CompletedStudy to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration
Pharmacokinetics
Phase 12017-11-30
TerminatedEfficacy and Safety Study of Ryanodex as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxi
Drug Toxicity Psychotropic Agents Psychostimulants
Phase 22017-08-12
CompletedEfficacy and Safety of Ryanodex® (EGL-4104) as Adjuvant Treatment in Subjects With Exertional Heat Stroke (EHS
Heat Stroke
Phase 22015-09-01
CompletedA Phase I, Bioequivalence Study to Evaluate Two Formulations of Bendamustine (BDM) Hydrochloride (HCl) Adminis
Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is Appropriate
Phase 12013-11-01